The effectiveness and cost-effectiveness of an integrated cardio-metabolic risk assessment and treatment program in primary care: the INTEGRATE study
- Conditions
- Cardiometabolic disease, prevention, screening, non-participation, primary care, effectiveness, economic evaluation.Cardiometabole ziekten, preventie, screening, non-participatie, eerstelijns gezondheidszorg, effectiviteit, economische evaluatie.
- Registration Number
- NL-OMON20643
- Lead Sponsor
- - NIVEL, Netherlands Institute for Health Services Research - University Medical Center Utrecht, Julius Center, - VU University Medical Center, EMGO Institute for health and care research, Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 28500
Inclusion Criteria
Inclusion criteria for practices:
- The use of an Electronic Medical Record (EMR) system, from which electronic data extraction is possible, covering approximately 90% of all Dutch general practices.
Exclusion Criteria
Exclusion criteria for practices:
- Previously performed systematic CMD screening of the entire or a non-random sample of the practice population.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The number of newly detected patients with a CMD in one year follow-up.<br /><br>2. Change in individual risk factor (smoking, physical inactivity, obesity, unhealthy diet, blood pressure and cholesterol levels) for CMD between baseline and one year follow-up. <br /><br>3. The expected number of newly detected patients with CMD and mortality after 5, 10, 20 years and lifetime.<br /><br>4. Costs-effectiveness of PPA CMR<br /><br>5. Non-participation and compliance in different stages of PPA CMR.
- Secondary Outcome Measures
Name Time Method 1. Difference in primary outcome 5 after implementation of different response-enhancing strategies.<br /><br>2. Change in willingness to change lifestyle between baseline and one year follow-up.<br /><br>3. Change in health status between baseline and one year follow up